Skip to main content
. 2018 Oct 4;151(1):100–107. doi: 10.1093/ajcp/aqy122

Table 3 .

Clinical Indication for the Prospective Cohort

Indication Total, No. (%) C belli Present, No. (%) C belli Absent, No. (%) P a
(n = 22) (n = 6) (n = 16)
Male 4 (18.2) 0 4 (25)
Indication
Dyskinesia 8 (36.4) 3 (50) 5 (31.3) .831
Cholecystitis 5 (22.7) 1 (16.7) 4 (25)
Gallstone disease 6 (27.2) 1 (16.7) 5 (31.3)
Polyp 2 (9.1) 1 (16.7) 1 (6.3)
Incidental 1 (4.5) 0 1 (6.3)

C belli, Cystoisospora belli.

aFisher exact test.